earnings
confidence high
sentiment positive
materiality 0.80
Orthofix reports Q3 preliminary net sales $114M, up 5% CC; announces SeaSpine merger
Orthofix Medical Inc.
2022-Q3 EPS reported
-$0.63
revenue$338,484,000
- Preliminary Q3 net sales $114M, +1% reported, +5% constant currency YoY; nine-month net sales $339M, flat reported.
- Global Orthopedics grew 19% CC; Biologics +8% CC; Bone Growth Therapies +3% CC; Spinal Implants -7% CC.
- Preliminary cash, cash equivalents and restricted cash ~$52M as of Sep 30, 2022.
- Entered all-stock merger of equals with SeaSpine (NASDAQ: SPNE) to create leading spine and orthopedics company.